Total visits last 3 months
| Last Month Change | 29.29% | 34.3% |
| Avg Visit Duration | 00:00:25 | 00:00:37 |
| Pages per Visit | 1.48 | 1.36 |
| Bounce Rate | 63.84% | 74.15% |
| Compare any site with a free trial | ||
tecentriq.com VS. 
adcetris.com
tecentriq.com
Hear from expert doctors as they discuss overall liver health, hepatocellular carcinoma (HCC), and treatment with TECENTRIQ® (atezolizumab) and Avastin® (bevacizumab) as a combination treatment option. See full safety for more information.
Global Rank
#2,402,034
adcetris.com
Discover the efficacy and safety data from the ECHELON-2 clinical study of 400 patients, including side effects and other safety information.
Global Rank
#2,156,814
tecentriq.com vs. adcetris.com Ranking Comparison
Compare tecentriq.com global ranking trend in the past 3 months vs. adcetris.com, or dive deeper into tecentriq.com ranking in its category or country measured against adcetris.com
Category Rank Last Month
adcetris.com
#797tecentriq.com
#1,041
Traffic and Engagement
adcetris.com had more total visits compared to tecentriq.com in June 2026.
Traffic share by country: tecentriq.com vs. adcetris.com
tecentriq.com vs adcetris.com country based traffic analysis shows tecentriq.com gets the most traffic from United States, while adcetris.com gets a smaller share
Top Countries
tecentriq.com
67.19%
adcetris.com
32.81%
United States